Kouroumalis E, Tsomidis I, Voumvouraki A. Iron as a therapeutic target in chronic liver disease. World J Gastroenterol 2023; 29(4): 616-655 [DOI: 10.3748/wjg.v29.i4.616][Reference Citation Analysis]
2
Li X, Gao Y, Wang Y, Wang Y, Wu Q. Prevalence and Influence Factors for Non-Alcoholic Fatty Liver Disease in Long-Term Hospitalized Patients with Schizophrenia: A Cross-Sectional Retrospective Study. Neuropsychiatr Dis Treat 2023;19:379-89. [PMID: 36846597 DOI: 10.2147/NDT.S398385][Reference Citation Analysis]
3
Gangopadhyay A, Ibrahim R, Theberge K, May M, Houseknecht KL. Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines. Front Neurosci 2022;16. [DOI: 10.3389/fnins.2022.1042442][Reference Citation Analysis]